CG-101 Eye Drops in the Treatment of Dry Eye Syndrome
Status:
RECRUITING
Trial end date:
2025-05-22
Target enrollment:
Participant gender:
Summary
This study is a single-center, randomized, double-blind, placebo-controlled, cross-over clinical trial designed to evaluate the effectiveness and safety of CG-101 eye drops for the treatment of dry eye syndrome, using a placebo as a control.